Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model

Administration of oral or IP bLF at different doses did not demonstrate antiviral activity or significant effects on disease severity in the RSV mouse model. Whether these observations could be extrapolated to infants at risk for RSV infection needs to be further explored.